Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 331.30
-8.70 (-2.56%)
Oct 28, 2025, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.51 trillion as of October 28, 2025. Its market cap has decreased by -57.05% in one year.
Market Cap
1.51T
Enterprise Value
1.59T
Revenue
311.94B
Ranking
n/a
PE Ratio
13.63
Stock Price
331.30
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.51T, an increase of 3,184.12%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 1.51T | -45.50% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | 986.61B | 8.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coloplast | 137.17B |
| Genmab | 117.60B |
| Demant | 49.93B |
| ALK-Abelló | 47.95B |
| H. Lundbeck | 43.82B |
| Zealand Pharma | 32.74B |
| Ambu A/S | 28.69B |
| Bavarian Nordic | 18.90B |